1. Peters WP: High Dose Chemotherapy with Autologous Bone Marrow Transplantation for the Treatment of Breast Cancer. Philadelphia, Lippincott, 1995
2. Peters WPJ, Vredenburgh RB, Shpall J, Hussein EJ, Elkordy A, Rubin M, Ross P, Berry M, D: A large, prospective, randomized trial of high-dose combination alkylating agents (CPB) with autologous cellular support (ABMS) as consolidation for patients with metastatic breast cancer achieving complete remission after intensive doxorubicin-based induction therapy (AFM). Proceedings of ASCO, 121, 1996
3. Lotz JP, Cure H, Janvier M, Morvan F, Legros M, Asselain B, Guillemot M, Roche H, Gisselbrecht C: Intensive chemotherapy and autograft of hematopoietic stem cells in the treatment of metastatic cancer: results of the national protocol Pegase 04. Hematol Cell Ther 41: 71–74, 1999
4. Stadtmauer EA, O'Neill A, Goldstein LJ, Crilley PA, Mangan KF, Ingle JN, Brodsky I, Martino S, Lazarus HM, Erban JK, Sickles C, Glick JH: Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer. Philadelphia Bone Marrow Transplant Group. N Engl J Med 342: 1069–1076, 2000
5. Peters WP, Dansey RD, Klein JL, Baynes RD: High-dose chemotherapy and peripheral blood progenitor cell transplantation in the treatment of breast cancer. Oncologist 5: 1–13, 2000